Author: K-STOCK Editor

[Disclosure] SK Square (402340) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

[Disclosure] SK Square (402340) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

Semiconductors

[Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14

[Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14

Semiconductors

[Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

[Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

Disclosures

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14

[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14

Disclosures

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-08-14

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-08-14

Disclosures

[Disclosure] Jusung Engineering (036930) – (Correction) Sales and Supply Contract / 2024-08-14

[Disclosure] Jusung Engineering (036930) – (Correction) Sales and Supply Contract / 2024-08-14

Semiconductors

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-08-12

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-08-12

Disclosures

[Disclosure] Hanwha Systems (272210) Signs KRW 84.0B Supply Contract with DAPA for ‘TOD-III Repair Parts PBL Project and 6 Other Items’

Disclosures

[Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2024-08-08

[Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2024-08-08

Semiconductors

[Disclosure] Celltrion (068270) – Additional Listing (Stock Option Exercise) / 2024-08-08

[Disclosure] Celltrion (068270) – Additional Listing (Stock Option Exercise) / 2024-08-08

Disclosures